Pharma Intelligence is part of the Informa Intelligence Division of Informa PLC
This is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
The pharmaceutical industry develops drugs and interventions that benefit society, allowing us to live healthier, happier, more productive, and more fulfilling lives. Between 2000 and 2009, medicines contributed 73% of the 21-month life expectancy increase. Medicines have also led to 83% of survival gains in cancer, and prevented 862,000 deaths since the mid-90s in the United States alone.
However, these new medicines don’t come without a struggle, and pharma R&D remains one of the highest risk business areas. In fact, 85% of medicines in development fail to reach approval while 30% of marketed drugs don’t make enough money to cover their R&D costs.
Clinical and research excellence has numerous interpretations and definitions, ranging from the unwavering commitment to identify a cure for the rarest, unmet needs to demonstrated innovation or R&D effectiveness. At Pharma Intelligence, we both celebrate and support the dialogue.
The CARE Index
Based on a series of key R&D indicators that leverage our proprietary R&D data sets, Pharma Intelligence developed a definitive index of clinical and research excellence. The CARE Index also allows you to create your own version by adjusting indicator weightings to reflect what clinical and research excellence means to you, and compare this with ones created by our analysts and journalists.
The CARE Awards
The CARE Awards are dedicated to recognizing clinical achievements in the pharmaceutical industry. The awards showcase excellence in clinical trial design, technological advancements and results, as well as the outstanding achievements of individuals, departments, teams or organizations. Winners will have contributed to the advancement of therapies for unmet medical needs, undertaken ground-breaking collaborations, and contributed to positive clinical outcomes, with a focus on best practice and innovation.
The CARE Awards 2018 took place April 25 at the Boston Harbor Hotel to celebrate the wealth of innovation, unwavering commitment and passion to make human lives better.
The CARE Awards 2017 was held in Boston in the State Room on Wednesday, April 5, 2017.
Clinical and Research Excellence Excellence
Pharma Intelligence is pleased to announce the launch of the third annual Clinical and Research Excellence (CARE) Awards.
Clinical and Research Excellence Excellence
In 2016, the Clinical Research & Excellence (CARE) Awards were launched to recognize the people and teams driving drug development, which continually grows in its complexity, especially within times of uncertainty. Since the inaugural ceremony, R&D pipelines continued to grow in size, but at a reduced rate of expansion.
Topic Research
Clinical and Research Excellence Excellence
With remote-only clinical trials now a reality [2] despite the inherent difficulties posed by the format, the digitisation of Pharma is closer than ever. Many categories exist into which software and devices can be divided to and differentiate them by the availability/ubiquity and intrusiveness to the patient.
Topic Clinical trials
Clinical and Research Excellence Excellence
Early phase trials are key to the drug development process, answering questions about safety, dosage, feasibility, and sometimes initial efficacy of a drug. As such, the Clinical and Research Excellence (CARE) Awards recognizes achievements within this vital aspect of R&D through the ‘Most Successful Early Phase Trial (Preclinical & Phase I)’ Award, honoring recent early phase trials that met or surpassed its objectives.
Clinical and Research Excellence Excellence
We are delighted to announce the finalists for the 2017 Clinical and Research Excellence Awards.
Clinical and Research Excellence Excellence
As previously mentioned, the ‘Clinical Trial Result of the Year’ CARE Award, award will recognize a group for their exceptional contribution to an area with unmet medical need.
Clinical and Research Excellence Excellence
During the Clinical and Research Excellence (CARE) Awards, the ‘Clinical Trial Result of the Year’ award will recognize a group for their exceptional contribution to an area with unmet medical need.
Clinical and Research Excellence Excellence
On April 5, 2017, the 2nd annual Clinical and Research Excellence (CARE) Awards ceremony will return to The State Room in Boston to celebrate key accomplishments in the pharma industry.
Clinical and Research Excellence Excellence
Last year, Pharma Intelligence launched the Clinical and Research Excellence (CARE) Awards to recognize and honor the vital contributions of those making a difference within clinical R&D.
To build and maintain gold-standard, next generation R&D intelligence tools, Sitetrove, Trialtrove, Pharmaprojects, and Trialpredict have been undergoing a major program of investment. In addition to the many new and exciting changes on the horizon, the robust and reliable Citeline tools that you use to inform your business decisions will formally join Informa’s Pharma Intelligence family of brands.
The industry’s most trusted drug development database, Citeline's Pharmaprojects has been covering pharma R&D across global markets for 35+ years. With 68,000+ drug profiles including 15,000 drugs in active development, it’s the go-to resource for preclinical, clinical, and pipeline coverage, and lifecycle management tracking.
Trialtrove is the go-to resource for clinical trial research. Easily track your competitors' clinical R&D activity with expert insights and continually monitored trials.
Looking for more products Product Finder
